Aptorum Group Limited (NASDAQ:APM) Short Interest Up 41.4% in March

Aptorum Group Limited (NASDAQ:APM) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 12,292 shares, a growth of 41.4% from the March 15th total of 8,693 shares. Based on an average trading volume of 145,672 shares, the short-interest ratio is presently 0.1 days. Currently, 0.5% of the shares of the stock are short sold.

Aptorum Group Trading Down 3.8%

Shares of APM opened at $0.88 on Tuesday. Aptorum Group has a 52 week low of $0.65 and a 52 week high of $4.47. The stock has a fifty day moving average of $0.86 and a 200-day moving average of $1.18.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Aptorum Group in a research note on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Aptorum Group Company Profile

Aptorum Group Ltd. (NASDAQ: APM) is a global biopharmaceutical company incorporated under the laws of the Cayman Islands and headquartered in Hong Kong. Since its Nasdaq listing in 2018, the company has focused on the discovery, development and commercialization of novel therapeutics and diagnostic products. Aptorum’s research efforts are aimed at addressing unmet medical needs across oncology, metabolic disorders, infectious diseases and neurological conditions.

The company’s diversified pipeline includes both small-molecule and biologic drug candidates, as well as companion diagnostic tools.